AT-527 is a Potent and Orally Active HCV Viral Replication Inhibitor
|There are approximately 71 million people globally who are chronically infected with the hepatitis C virus (HCV). The chronic infection of HCV may result in cirrhosis, hepatocellular carcinoma, or liver…